IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer
Go back to IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer| (NASDAQ: IMNN) | Delayed: 1.54 -0.04 (2.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.58 | 52 Week High | $ | |||
| Open | $1.56 | 52 Week Low | $ | |||
| Day High | $1.60 | P/E | N/A | |||
| Day Low | $1.53 | EPS | $ | |||
| Volume | 40,838 | |||||
